NZMP and Maypro have entered into an agreement in which Maypro will be an authorized reseller of NZMP’s BifidoB HN019 and LactoB HN001 probiotic strains in North America, as well as new strains in development.
NZMP (Chicago, IL) and Maypro (Purchase, NY) have entered into an agreement in which Maypro will be an authorized reseller of NZMP’s BifidoB HN019 and LactoB HN001 probiotic strains in North America, as well as new strains in development. The strains were first discovered and commercialized by NZMP’s parent company, Fonterra. They have been extensively researched with over 60 combined human clinical trials which have shown a range of consumer benefits, including digestive health, immunity, skin health, women's health and post-natal depression. NZMP’s probiotic strains have comprehensive certifications including vegan, vegetarian, non-dairy, organic, halal, kosher and non-GMO project verified, as well as proven stability in a range of dosage formats such as capsules and sachets, yogurts, ice creams, chocolate and coatings and high-pressure processed juices.
"This agreement with Maypro is important to brands already using probiotic ingredients as well brands looking to develop new products with health claims in mood, stress, anxiety, skin health, digestive health and immunity," says Chris Ireland, senior manager business development, NZMP, in a press release. "This agreement will allow us to both extend our sales force and harness Maypro's valuable supplement customer network."
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
2 Commerce Drive
Cranbury, NJ 08512